The Challenges of Melanoma during COVID-19 Pandemic
| Autor: | Diana Spinu, Florica Sandru, Dan Nicolae Păduraru, Raluca-Gabriela Miulescu, Adelina Popa, Carmen Cristina Draghici, Octavian Andronic, Dumitru Ferechide, Mihai Cristian Dumitrascu |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty 2019-20 coronavirus outbreak Medicine (General) Coronavirus disease 2019 (COVID-19) esmo guidelines 03 medical and health sciences 0302 clinical medicine R5-920 Pandemic medicine melanoma Risks and benefits Stage (cooking) Intensive care medicine business.industry target therapy Melanoma covid-19 pandemic Cancer General Medicine medicine.disease 030104 developmental biology 030220 oncology & carcinogenesis Medicine immunotherapy Skin cancer business |
| Zdroj: | Modern Medicine, Vol 27, Iss 3, Pp 167-170 (2020) |
| ISSN: | 2360-2473 1223-0472 |
| Popis: | Diagnosis, tratament and follow-up of patients with melanoma during COVID-19 pandemic is quite challenging. These patients are often immunocompromised, but, on the other hand, management of this malignant skin cancer should not be delayed. It is necessary to diagnose and stage the melanoma as soon as possible, in an attempt to provide a better prognosis. There are few data regarding the treatament of melanoma during COVID-19 pandemia. However, the general recommandations suggest testing all cancer patients prior administration of the therapy. The European Society for Medical Oncology (ESMO) provided guidelines regarding therapy of this skin cancer during COVID-19 pandemic. Every patient is different, and it is always important to evaluate the risks and benefits. © 2020 Universidade do Porto - Faculdade de Engenharia. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|